{"gene":"PF3D7_0319700","run_date":"2026-09-07T10:55:51","timeline":{"discoveries":[{"year":2021,"finding":"Point mutations in ABCI3 (PF3D7_0319700) were identified as the primary mediator of resistance to three carboxamide-containing antimalarial compounds, confirmed by gene editing and conditional knockdowns; additionally, gene amplification of ABCI3 was selected by imidazopyridine or quinoline-carboxamide compounds, establishing ABCI3 as a determinant of pleiotropic drug resistance in a strain-dependent manner.","method":"Resistance selection studies, gene editing, conditional knockdowns, and cellular heme fractionation assays","journal":"Cell chemical biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal genetic confirmation via gene editing and conditional knockdown with defined phenotypic readout; multiple orthogonal methods in a single study","pmids":["34233174"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2023,"finding":"ABCI3 (PF3D7_0319700) can operate in concert with PfCRT and plasmepsins 2/3 to mediate multigenic resistance to antimalarial agents, as established by genetic cross, bulk segregant analysis, QTL mapping, and gene editing in humanized mice.","method":"P. falciparum genetic cross in humanized mice, bulk segregant analysis, quantitative trait loci mapping, gene editing","journal":"Science advances","confidence":"High","confidence_rationale":"Tier 2 / Strong — epistasis confirmed by gene editing and QTL mapping with multiple orthogonal methods; published peer-reviewed and replicated across preprint and final paper","pmids":["37939186","37398288"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":"KEL1/PLA1"}]},{"year":2021,"finding":"Resistance to the novel antimalarial chemotype DDD01034957 is linked to the membrane transporter ABCI3 (PF3D7_0319700), as demonstrated by resistance selection studies.","method":"In vitro resistance selection and whole genome sequencing","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — resistance selection with whole genome sequencing, single lab, but no direct gene editing confirmation reported in this paper","pmids":["33479319"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2024,"finding":"Resistance to pyrazolopyridine 4-carboxamide antimalarials is associated with the ABCI3 transporter (PF3D7_0319700); knockdown of ABCI3 increased compound potency against parasites, confirming the transporter's role in mediating resistance to this chemotype.","method":"Resistance selection, ABCI3 knockdown with potency assay","journal":"European journal of medicinal chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional knockdown with defined potency phenotype, single lab, replicates prior findings with this chemotype class","pmids":["39024967"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2025,"finding":"Resistance to pyrimidine-2,4-diamine antimalarial W482 is mediated by amplification of the ABCI3 gene (PF3D7_0319700); parasites with reduced ABCI3 expression showed greater susceptibility to W482, confirming the transporter's role in resistance.","method":"Resistance selection, whole genome sequencing, ABCI3 expression reduction with susceptibility assay","journal":"ChemMedChem","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gene expression reduction with defined susceptibility phenotype and WGS confirmation, single lab","pmids":["41387370"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]}],"current_model":"ABCI3 (PF3D7_0319700) is a P. falciparum ABC transporter whose point mutations or gene amplification mediate pleiotropic resistance to multiple structurally distinct antimalarial compounds, and which can act epistatically with PfCRT and plasmepsins 2/3 in multigenic drug resistance; conditional knockdown and gene editing confirm its direct role, though its endogenous substrate and transport mechanism remain uncharacterized."},"narrative":{"mechanistic_narrative":"ABCI3 (PF3D7_0319700) is a Plasmodium falciparum ABC-family membrane transporter that functions as a determinant of pleiotropic resistance to multiple structurally distinct antimalarial chemotypes [PMID:34233174]. Resistance is achieved through two genetic mechanisms: point mutations in ABCI3 confer resistance to carboxamide-containing compounds, while gene amplification is selected by imidazopyridine and quinoline-carboxamide compounds, with the effect being strain-dependent [PMID:34233174]. Reciprocal genetic manipulation supports a direct role: conditional knockdown or reduced ABCI3 expression increases parasite susceptibility to associated chemotypes, and gene editing confirms causality [PMID:34233174, PMID:39024967, PMID:41387370]. ABCI3 does not act in isolation in the resistance landscape—it can operate epistatically with PfCRT and plasmepsins 2/3 to produce multigenic resistance, as resolved by genetic cross, bulk segregant analysis, and QTL mapping in humanized mice [PMID:37939186, PMID:37398288]. The endogenous substrate and transport mechanism of ABCI3 have not been characterized in the available corpus; its role is defined entirely through drug-resistance phenotypes rather than a defined physiological transport function.","teleology":[{"year":2021,"claim":"Establishing which parasite factor accounts for resistance to a novel carboxamide chemotype series identified ABCI3 as a causal, genetically confirmed resistance determinant rather than a correlate.","evidence":"Resistance selection, gene editing, and conditional knockdown with heme fractionation readout in P. falciparum","pmids":["34233174"],"confidence":"High","gaps":["The endogenous transported substrate of ABCI3 is not identified","The molecular mechanism by which point mutation versus amplification confers resistance is not resolved","The basis of strain-dependence is not defined"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2021,"claim":"Linking a second, structurally unrelated chemotype (DDD01034957) to ABCI3 tested whether the transporter's resistance role generalizes beyond carboxamides, supporting a pleiotropic function.","evidence":"In vitro resistance selection and whole genome sequencing in P. falciparum","pmids":["33479319"],"confidence":"Medium","gaps":["No direct gene-editing confirmation reported in this study","Whether the same mutations mediate resistance across chemotypes is not established"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2023,"claim":"Determining whether ABCI3 acts alone or within a multigenic network showed it operates epistatically with PfCRT and plasmepsins 2/3, placing it in a combinatorial resistance architecture.","evidence":"P. falciparum genetic cross in humanized mice, bulk segregant analysis, QTL mapping, and gene editing","pmids":["37939186","37398288"],"confidence":"High","gaps":["The biochemical nature of the interaction with PfCRT and plasmepsins 2/3 is not defined","Whether these factors converge on a shared substrate or pathway is unknown"],"attribution":[{"species":"Plasmodium falciparum","strain":"KEL1/PLA1"}]},{"year":2024,"claim":"Extending the resistance association to pyrazolopyridine 4-carboxamides with a reciprocal knockdown readout reinforced that lowering ABCI3 restores compound potency, confirming its causal role for an additional chemotype.","evidence":"Resistance selection and ABCI3 knockdown coupled to a potency assay in P. falciparum","pmids":["39024967"],"confidence":"Medium","gaps":["Single-lab result replicating a prior chemotype class","Mechanism linking transporter level to potency is not resolved"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2025,"claim":"Associating pyrimidine-2,4-diamine W482 resistance with ABCI3 amplification, and showing reduced expression increases susceptibility, demonstrated gene-dosage as a distinct resistance mechanism for another chemotype.","evidence":"Resistance selection, whole genome sequencing, and ABCI3 expression reduction with susceptibility assay in P. falciparum","pmids":["41387370"],"confidence":"Medium","gaps":["Single-lab result","How copy-number increase translates to drug efflux or sequestration is not established"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":null,"claim":"The endogenous physiological substrate, direction of transport, and biochemical transport mechanism of ABCI3 remain unknown, as does the structural basis by which mutations and amplification confer resistance.","evidence":"","pmids":[],"confidence":"Low","gaps":["No native substrate identified","No structural or transport-mechanism model established","Subcellular localization within the parasite not defined in the corpus"],"attribution":[]}],"mechanism_profile":{"molecular_activity":[],"localization":[],"pathway":[],"complexes":[],"partners":["PFCRT (GENETIC EPISTASIS IN MULTIGENIC RESISTANCE) [#1]","PLASMEPSIN 2/3 (GENETIC EPISTASIS IN MULTIGENIC RESISTANCE) [#1]"],"other_free_text":["Resistance to carboxamide-containing antimalarials is mediated by point mutations in ABCI3 [#0].","Gene amplification of ABCI3 is selected by imidazopyridine and quinoline-carboxamide compounds and mediates resistance to pyrimidine-2,4-diamine W482 [#0, #4].","ABCI3 confers pleiotropic resistance to multiple structurally distinct chemotypes including DDD01034957 and pyrazolopyridine 4-carboxamides [#2, #3].","Resistance effect is strain-dependent [#0].","Endogenous substrate and transport mechanism remain uncharacterized in the available corpus."]}},"prefetch_data":{},"corpus_meta":[{"pmid":"15774027","id":"PMC_15774027","title":"The 'permeome' of the malaria parasite: an overview of the membrane transport proteins of Plasmodium falciparum.","date":"2005","source":"Genome biology","url":"https://pubmed.ncbi.nlm.nih.gov/15774027","citation_count":146,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["curated_ref"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"9693718","id":"PMC_9693718","title":"The ABC family of multidrug transporters in microorganisms.","date":"1998","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/9693718","citation_count":139,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ABC"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"11421285","id":"PMC_11421285","title":"Fungal ABC proteins: pleiotropic drug resistance, stress response and cellular detoxification.","date":"2001","source":"Research in microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/11421285","citation_count":113,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ABC"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"15917511","id":"PMC_15917511","title":"Are transporter genes other than the chloroquine resistance locus (pfcrt) and multidrug resistance gene (pfmdr) associated with antimalarial drug resistance?","date":"2005","source":"Antimicrobial agents and chemotherapy","url":"https://pubmed.ncbi.nlm.nih.gov/15917511","citation_count":95,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ABC"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"21633513","id":"PMC_21633513","title":"Novel polymorphisms in Plasmodium falciparum ABC transporter genes are associated with major ACT antimalarial drug resistance.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21633513","citation_count":86,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ABC"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"20541973","id":"PMC_20541973","title":"The ABCs of multidrug resistance in malaria.","date":"2010","source":"Trends in parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/20541973","citation_count":78,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ABC"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"26796412","id":"PMC_26796412","title":"Functional profiles of orphan membrane transporters in the life cycle of the malaria parasite.","date":"2016","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/26796412","citation_count":75,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["curated_ref"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"13678838","id":"PMC_13678838","title":"ABC transporters and drug resistance in parasitic protozoa.","date":"2003","source":"International journal of antimicrobial agents","url":"https://pubmed.ncbi.nlm.nih.gov/13678838","citation_count":66,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ABC"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"19715599","id":"PMC_19715599","title":"Localization of the ATP-binding cassette (ABC) transport proteins PfMRP1, PfMRP2, and PfMDR5 at the Plasmodium falciparum plasma membrane.","date":"2009","source":"Malaria journal","url":"https://pubmed.ncbi.nlm.nih.gov/19715599","citation_count":39,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ABC","PfABC","PfABCI3"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"9201967","id":"PMC_9201967","title":"Functional interactions between synthetic alkyl phospholipids and the ABC transporters P-glycoprotein, Ste-6, MRP, and Pgh 1.","date":"1997","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9201967","citation_count":38,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ABC"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"15275221","id":"PMC_15275221","title":"The ATP-binding cassette (ABC) gene family of Plasmodium falciparum.","date":"1996","source":"Parasitology today (Personal ed.)","url":"https://pubmed.ncbi.nlm.nih.gov/15275221","citation_count":36,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ABC"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"11512154","id":"PMC_11512154","title":"The ABC transporter genes of Plasmodium falciparum and drug resistance.","date":"2001","source":"Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy","url":"https://pubmed.ncbi.nlm.nih.gov/11512154","citation_count":35,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ABC"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"8097560","id":"PMC_8097560","title":"Nucleotide binding properties of a P-glycoprotein homologue from Plasmodium falciparum.","date":"1993","source":"Molecular and biochemical parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/8097560","citation_count":35,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ABC"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"37939186","id":"PMC_37939186","title":"Mapping the genomic landscape of multidrug resistance in Plasmodium falciparum and its impact on parasite fitness.","date":"2023","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/37939186","citation_count":32,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ABCI3"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"36844008","id":"PMC_36844008","title":"Population-based genomic study of Plasmodium vivax malaria in seven Brazilian states and across South America.","date":"2023","source":"Lancet regional health. Americas","url":"https://pubmed.ncbi.nlm.nih.gov/36844008","citation_count":27,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ABC","PvABCI3"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"20392668","id":"PMC_20392668","title":"Exploiting the therapeutic potential of Plasmodium falciparum solute transporters.","date":"2010","source":"Trends in parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/20392668","citation_count":24,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ABC"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"34233174","id":"PMC_34233174","title":"The Plasmodium falciparum ABC transporter ABCI3 confers parasite strain-dependent pleiotropic antimalarial drug resistance.","date":"2021","source":"Cell chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/34233174","citation_count":23,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ABCI3","ABC"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"23541983","id":"PMC_23541983","title":"Chemosensitization potential of P-glycoprotein inhibitors in malaria parasites.","date":"2013","source":"Experimental parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/23541983","citation_count":15,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ABC"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"35153639","id":"PMC_35153639","title":"Momordica balsamina: phytochemistry and pharmacological potential of a gifted species.","date":"2022","source":"Phytochemistry reviews : proceedings of the Phytochemical Society of Europe","url":"https://pubmed.ncbi.nlm.nih.gov/35153639","citation_count":13,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ABC"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"19819706","id":"PMC_19819706","title":"Antimalarial and antitrypanosomal activity of a series of amide and sulfonamide derivatives of a 2,5-diaminobenzophenone.","date":"2009","source":"Bioorganic & medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19819706","citation_count":12,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ABC"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"37158739","id":"PMC_37158739","title":"Susceptibility of Ugandan Plasmodium falciparum Isolates to the Antimalarial Drug Pipeline.","date":"2023","source":"Microbiology spectrum","url":"https://pubmed.ncbi.nlm.nih.gov/37158739","citation_count":8,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ABC"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"33479319","id":"PMC_33479319","title":"The antimalarial efficacy and mechanism of resistance of the novel chemotype DDD01034957.","date":"2021","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/33479319","citation_count":8,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["PfABCI3"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"39024967","id":"PMC_39024967","title":"Optimization of pyrazolopyridine 4-carboxamides with potent antimalarial activity for which resistance is associated with the P. falciparum transporter ABCI3.","date":"2024","source":"European journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/39024967","citation_count":7,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ABCI3"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"41387370","id":"PMC_41387370","title":"Exploration and Characterization of the Antimalarial Activity of Pyrimidine-2,4-Diamines for which Resistance is Mediated by the ABCI3 Transporter.","date":"2025","source":"ChemMedChem","url":"https://pubmed.ncbi.nlm.nih.gov/41387370","citation_count":1,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ABCI3"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"37398288","id":"PMC_37398288","title":"Mapping the genomic landscape of multidrug resistance in Plasmodium falciparum and its impact on parasite fitness.","date":"2023","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/37398288","citation_count":0,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ABCI3"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"14564508","id":"PMC_14564508","title":"Identification and expression analysis of ABC genes in Plasmodium yoelii and P. berghei.","date":"2003","source":"Parasitology research","url":"https://pubmed.ncbi.nlm.nih.gov/14564508","citation_count":4,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ABC"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":14625,"output_tokens":1288,"usd":0.031598,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":6261,"output_tokens":2509,"usd":0.047015,"stage2_stop_reason":"end_turn"},"total_usd":0.078613,"stage1_batch_id":"msgbatch_01DbiymDmubkPpYvdbAu5a7V","stage2_batch_id":"msgbatch_012TbrWvMRH129T7PQ4SmvrJ","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2021,\n      \"finding\": \"Point mutations in ABCI3 (PF3D7_0319700) were identified as the primary mediator of resistance to three carboxamide-containing antimalarial compounds, confirmed by gene editing and conditional knockdowns; additionally, gene amplification of ABCI3 was selected by imidazopyridine or quinoline-carboxamide compounds, establishing ABCI3 as a determinant of pleiotropic drug resistance in a strain-dependent manner.\",\n      \"method\": \"Resistance selection studies, gene editing, conditional knockdowns, and cellular heme fractionation assays\",\n      \"journal\": \"Cell chemical biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal genetic confirmation via gene editing and conditional knockdown with defined phenotypic readout; multiple orthogonal methods in a single study\",\n      \"pmids\": [\"34233174\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"ABCI3 (PF3D7_0319700) can operate in concert with PfCRT and plasmepsins 2/3 to mediate multigenic resistance to antimalarial agents, as established by genetic cross, bulk segregant analysis, QTL mapping, and gene editing in humanized mice.\",\n      \"method\": \"P. falciparum genetic cross in humanized mice, bulk segregant analysis, quantitative trait loci mapping, gene editing\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — epistasis confirmed by gene editing and QTL mapping with multiple orthogonal methods; published peer-reviewed and replicated across preprint and final paper\",\n      \"pmids\": [\"37939186\", \"37398288\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"KEL1/PLA1\"}]\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Resistance to the novel antimalarial chemotype DDD01034957 is linked to the membrane transporter ABCI3 (PF3D7_0319700), as demonstrated by resistance selection studies.\",\n      \"method\": \"In vitro resistance selection and whole genome sequencing\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — resistance selection with whole genome sequencing, single lab, but no direct gene editing confirmation reported in this paper\",\n      \"pmids\": [\"33479319\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Resistance to pyrazolopyridine 4-carboxamide antimalarials is associated with the ABCI3 transporter (PF3D7_0319700); knockdown of ABCI3 increased compound potency against parasites, confirming the transporter's role in mediating resistance to this chemotype.\",\n      \"method\": \"Resistance selection, ABCI3 knockdown with potency assay\",\n      \"journal\": \"European journal of medicinal chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional knockdown with defined potency phenotype, single lab, replicates prior findings with this chemotype class\",\n      \"pmids\": [\"39024967\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Resistance to pyrimidine-2,4-diamine antimalarial W482 is mediated by amplification of the ABCI3 gene (PF3D7_0319700); parasites with reduced ABCI3 expression showed greater susceptibility to W482, confirming the transporter's role in resistance.\",\n      \"method\": \"Resistance selection, whole genome sequencing, ABCI3 expression reduction with susceptibility assay\",\n      \"journal\": \"ChemMedChem\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gene expression reduction with defined susceptibility phenotype and WGS confirmation, single lab\",\n      \"pmids\": [\"41387370\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    }\n  ],\n  \"current_model\": \"ABCI3 (PF3D7_0319700) is a P. falciparum ABC transporter whose point mutations or gene amplification mediate pleiotropic resistance to multiple structurally distinct antimalarial compounds, and which can act epistatically with PfCRT and plasmepsins 2/3 in multigenic drug resistance; conditional knockdown and gene editing confirm its direct role, though its endogenous substrate and transport mechanism remain uncharacterized.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"ABCI3 (PF3D7_0319700) is a Plasmodium falciparum ABC-family membrane transporter that functions as a determinant of pleiotropic resistance to multiple structurally distinct antimalarial chemotypes [#0]. Resistance is achieved through two genetic mechanisms: point mutations in ABCI3 confer resistance to carboxamide-containing compounds, while gene amplification is selected by imidazopyridine and quinoline-carboxamide compounds, with the effect being strain-dependent [#0]. Reciprocal genetic manipulation supports a direct role: conditional knockdown or reduced ABCI3 expression increases parasite susceptibility to associated chemotypes, and gene editing confirms causality [#0, #3, #4]. ABCI3 does not act in isolation in the resistance landscape—it can operate epistatically with PfCRT and plasmepsins 2/3 to produce multigenic resistance, as resolved by genetic cross, bulk segregant analysis, and QTL mapping in humanized mice [#1]. The endogenous substrate and transport mechanism of ABCI3 have not been characterized in the available corpus; its role is defined entirely through drug-resistance phenotypes rather than a defined physiological transport function.\",\n  \"teleology\": [\n    {\n      \"year\": 2021,\n      \"claim\": \"Establishing which parasite factor accounts for resistance to a novel carboxamide chemotype series identified ABCI3 as a causal, genetically confirmed resistance determinant rather than a correlate.\",\n      \"evidence\": \"Resistance selection, gene editing, and conditional knockdown with heme fractionation readout in P. falciparum\",\n      \"pmids\": [\"34233174\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"The endogenous transported substrate of ABCI3 is not identified\",\n        \"The molecular mechanism by which point mutation versus amplification confers resistance is not resolved\",\n        \"The basis of strain-dependence is not defined\"\n      ],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Linking a second, structurally unrelated chemotype (DDD01034957) to ABCI3 tested whether the transporter's resistance role generalizes beyond carboxamides, supporting a pleiotropic function.\",\n      \"evidence\": \"In vitro resistance selection and whole genome sequencing in P. falciparum\",\n      \"pmids\": [\"33479319\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No direct gene-editing confirmation reported in this study\",\n        \"Whether the same mutations mediate resistance across chemotypes is not established\"\n      ],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Determining whether ABCI3 acts alone or within a multigenic network showed it operates epistatically with PfCRT and plasmepsins 2/3, placing it in a combinatorial resistance architecture.\",\n      \"evidence\": \"P. falciparum genetic cross in humanized mice, bulk segregant analysis, QTL mapping, and gene editing\",\n      \"pmids\": [\"37939186\", \"37398288\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"The biochemical nature of the interaction with PfCRT and plasmepsins 2/3 is not defined\",\n        \"Whether these factors converge on a shared substrate or pathway is unknown\"\n      ],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"KEL1/PLA1\"}]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Extending the resistance association to pyrazolopyridine 4-carboxamides with a reciprocal knockdown readout reinforced that lowering ABCI3 restores compound potency, confirming its causal role for an additional chemotype.\",\n      \"evidence\": \"Resistance selection and ABCI3 knockdown coupled to a potency assay in P. falciparum\",\n      \"pmids\": [\"39024967\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Single-lab result replicating a prior chemotype class\",\n        \"Mechanism linking transporter level to potency is not resolved\"\n      ],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Associating pyrimidine-2,4-diamine W482 resistance with ABCI3 amplification, and showing reduced expression increases susceptibility, demonstrated gene-dosage as a distinct resistance mechanism for another chemotype.\",\n      \"evidence\": \"Resistance selection, whole genome sequencing, and ABCI3 expression reduction with susceptibility assay in P. falciparum\",\n      \"pmids\": [\"41387370\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Single-lab result\",\n        \"How copy-number increase translates to drug efflux or sequestration is not established\"\n      ],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The endogenous physiological substrate, direction of transport, and biochemical transport mechanism of ABCI3 remain unknown, as does the structural basis by which mutations and amplification confer resistance.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No native substrate identified\",\n        \"No structural or transport-mechanism model established\",\n        \"Subcellular localization within the parasite not defined in the corpus\"\n      ],\n      \"attribution\": []\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0042626\", \"supporting_discovery_ids\": [0, 3, 4]},\n      {\"term_id\": \"GO:0015893\", \"supporting_discovery_ids\": [0, 3]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0016020\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0042493\", \"supporting_discovery_ids\": [0, 1, 2, 3, 4]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"PfCRT (genetic epistasis in multigenic resistance) [#1]\",\n      \"Plasmepsin 2/3 (genetic epistasis in multigenic resistance) [#1]\"\n    ],\n    \"other_free_text\": [\n      \"Resistance to carboxamide-containing antimalarials is mediated by point mutations in ABCI3 [#0].\",\n      \"Gene amplification of ABCI3 is selected by imidazopyridine and quinoline-carboxamide compounds and mediates resistance to pyrimidine-2,4-diamine W482 [#0, #4].\",\n      \"ABCI3 confers pleiotropic resistance to multiple structurally distinct chemotypes including DDD01034957 and pyrazolopyridine 4-carboxamides [#2, #3].\",\n      \"Resistance effect is strain-dependent [#0].\",\n      \"Endogenous substrate and transport mechanism remain uncharacterized in the available corpus.\"\n    ]\n  }\n}","audit_flag":null,"strains":[{"strain":"Pf3D7","gene_id":"PF3D7_0319700","name":null,"product":"ABC transporter I family member 1, putative","uniprot_acc":null,"chromosome":null,"start_pos":null},{"strain":"PbANKA","gene_id":"PBANKA_1218800","name":null,"product":"ABC transporter I family member 1, putative","uniprot_acc":null,"chromosome":null,"start_pos":null},{"strain":"PkH","gene_id":"PKNH_0821500","name":null,"product":"ABC transporter I family member 1, putative","uniprot_acc":null,"chromosome":null,"start_pos":null}],"gene_symbol":"ABCI3","evaluation":null}